Your browser doesn't support javascript.
loading
Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study.
Conley, Claire C; McIntyre, McKenzie; Pensak, Nicole A; Lynce, Filipa; Graham, Deena; Ismail-Khan, Roohi; Lopez, Katherine; Vadaparampil, Susan T; O'Neill, Suzanne C.
Affiliation
  • Conley CC; Georgetown Lombardi Comprehensive Cancer Center, 2115 Wisconsin Ave NW, Suite 300, Washington, DC, 20007, USA. claire.conley@georgetown.edu.
  • McIntyre M; Moffitt Cancer Center, Tampa, FL, USA. claire.conley@georgetown.edu.
  • Pensak NA; Moffitt Cancer Center, Tampa, FL, USA.
  • Lynce F; Atlantic Coast Mind & Body, Red Bank, NJ, USA.
  • Graham D; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ismail-Khan R; Hackensack University Medical Center, Hackensack, NJ, USA.
  • Lopez K; Moffitt Cancer Center, Tampa, FL, USA.
  • Vadaparampil ST; Georgetown Lombardi Comprehensive Cancer Center, 2115 Wisconsin Ave NW, Suite 300, Washington, DC, 20007, USA.
  • O'Neill SC; Moffitt Cancer Center, Tampa, FL, USA.
Breast Cancer Res Treat ; 192(2): 385-399, 2022 Apr.
Article in En | MEDLINE | ID: mdl-34997364
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Cyclin-Dependent Kinase 6 Type of study: Prognostic_studies / Qualitative_research Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Cyclin-Dependent Kinase 6 Type of study: Prognostic_studies / Qualitative_research Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2022 Document type: Article Affiliation country: Country of publication: